2016
DOI: 10.1016/j.ajo.2016.04.014
|View full text |Cite
|
Sign up to set email alerts
|

The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
48
0
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 31 publications
(52 citation statements)
references
References 19 publications
0
48
0
4
Order By: Relevance
“…In Mexico approximately 24% of childhood blindness occurs as a result of ROP, with large variations by regions. 27,28 It can be a challenge to acquire accurate healthcare statistics in Mexico. The last relevant reports by the Grupo ROP México are from 2011.…”
Section: Rop In Mexicomentioning
confidence: 99%
See 2 more Smart Citations
“…In Mexico approximately 24% of childhood blindness occurs as a result of ROP, with large variations by regions. 27,28 It can be a challenge to acquire accurate healthcare statistics in Mexico. The last relevant reports by the Grupo ROP México are from 2011.…”
Section: Rop In Mexicomentioning
confidence: 99%
“…The economic impact of ROP on our society is high. 27 Our group participated in the development of the the Economic Model of Retinopathy of Prematurity (EcROP), which showed that the cost per neonate treated in Mexico is estimated to be $3,228 USD; parental indirect cost due to estimated lost wages and productivity was $305,584 USD; and a lifetime loss of productivity resulting from a blind individual was $142,172 USD.…”
Section: Rop In Mexicomentioning
confidence: 99%
See 1 more Smart Citation
“…[42] ROP telemedicine screening has additionally been shown to be cost-effective in both developed and developing nations. [3, 43]…”
Section: Retinopathy Of Prematurity and Other Pediatric Retinal Diseasesmentioning
confidence: 99%
“…Nevertheless, telemedicine may prove to be cost-effective in the longer term. [3] Implementation of reliable, accurate and dependable new telemedicine systems additionally requires rigorous validation, standardization, and regulation.…”
Section: Introductionmentioning
confidence: 99%